跳至主要内容
临床试验/CTRI/2016/12/007532
CTRI/2016/12/007532招募中3 期

Post-Mastectomy Radiation Therapy in High Risk, Node Negative women with Early Breast Cancer (PMRT-NNBC) - PMRT-NNBC

Tata Memorial Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • i.Women with unilateral pT1,2N0M0 breast cancer or multifocal breast cancer if largest discrete tumour at least 2cm or if the tumour area comprises multiple small adjacent foci of invasive carcinoma then overall maximum dimension taken. This must be greater than 2cm.
  • ii.Upfront total mastectomy (with minimum 1 mm margin clear of invasive cancer or DCIS) and axillary staging procedure (clearance, sampling or SNB)
  • iii.T2 tumors with one risk factor or T1 tumors with any of the following two high risk factors such as presence of high grade, lymphovascular invasion, ER/PR negative, HER2 positivity, age < 35 years.
  • iv.Fit to receive adjuvant radiation +/- chemotherapy (if indicated) +/- hormonal therapy (if indicated)
  • v.Written, informed consent

排除标准

  • i.Any pTis/3/4, M1 patients
  • ii.Patients who have any pathologically involved axillary nodes (micromets may be allowed)
  • iii.Patients who have undergone neoadjuvant systemic therapy.
  • iv.Previous or concurrent malignancy other than non melanomatous skin cancer and carcinoma in situ of the cervix
  • v.Pregnancy
  • vi.Bilateral breast cancer
  • vii.Not fit for surgery, radiotherapy or adjuvant systemic therapy
  • viii.Unable or unwilling to give informed consent

研究者

相似试验